About NanoDecoder
NanoDecoder is a company based in China founded in 2020 by Chan Cao and Zhidian Zhang. NanoDecoder offers products and services including NanoReader and NanoCassette. NanoDecoder operates in a competitive market with competitors including Intraprise Health, CyberMDX, ADx NeuroSciences, Cytox and Amprion, among others.
- Headquarter China
- Founders Chan Cao, Zhidian Zhang
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$102.87 K (USD), Grant
Jul 08, 2022
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NanoDecoder
NanoDecoder offers a comprehensive portfolio of products and services, including NanoReader and NanoCassette.
Portable workstation for real-time DNA sequencing via nanopore technology.
Integrated chip for immediate nanopore sensing in DNA sample analysis.
Funding Insights of NanoDecoder
Investors in NanoDecoder
NanoDecoder has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include FIT.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Grants and loans are provided by FIT for innovative startups.
|
Locked | Locked | Locked |
Investor details for NanoDecoder
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NanoDecoder
Investment portfolio details for NanoDecoder
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - NanoDecoder
Detailed financials for NanoDecoder
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nanodecoder Comparisons
Peer comparison for NanoDecoder
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NanoDecoder
NanoDecoder operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Intraprise Health, CyberMDX, ADx NeuroSciences, Cytox and Amprion, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Patient engagement and care coordination solution for healthcare providers
|
|
| Locked | Locked | Locked |
AI-based cybersecurity solutions for healthcare networks are delivered.
|
|
| Locked | Locked | Locked |
Biomarker assays for neurodegenerative diseases are developed using custom antibodies.
|
|
| Locked | Locked | Locked |
Prognostic tests for assessing dementia risk are developed.
|
|
| Locked | Locked | Locked |
Assay technology for misfolded proteins in neurodegenerative disorders is developed.
|
|
| Locked | Locked | Locked |
Immunoassays are developed for early detection of neurodegenerative diseases.
|
Detailed competitors of NanoDecoder
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nanodecoder
Complete news archive for NanoDecoder
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NanoDecoder
NanoDecoder was founded in 2020 and raised its 1st funding round 2 years after it was founded.
NanoDecoder is headquartered in China.
NanoDecoder was founded in 2020 as a spinoff from EPFL and is based in China. Operations center on nanotechnology and machine learning within the health and authentication sectors. Molecular tags are attached to products for verification via nanopore sensing, while diagnostics devices combine nanopore technology with ML algorithms to detect diseases. Scientific excellence is emphasized in addressing counterfeiting and health challenges.
NanoDecoder's top competitors include Intraprise Health, CyberMDX and Amprion.
NanoDecoder offers NanoReader and NanoCassette.
NanoDecoder has 1 investor. Key investors include FIT.